Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daria A. Khavkina"'
Autor:
T. A. Ruzhencova, Daria А. Khavkina, Natalia A. Meshkova, Pavel V. Chukhliaev, Alexander A. Garbuzov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 8, Iss 2, Pp 77-83 (2020)
Abstract. The paper discusses specific features of acute respiratory infections (ARI) progression in patients with comorbidity. The relevance of this study is accounted for by severe progression of ARIs in this group of patients, as well as by specif
Externí odkaz:
https://doaj.org/article/d82a43de104e46f29ba17deeb6844d70
Autor:
Pavel V. Chuchliaev, Maria V. Nikolskaya, Viktoria A. Razzhivina, Alexander A. Garbuzov, Daria A. Khavkina, Tatiana A. Ruzhentsova, Olga V. Filon
Publikováno v:
Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. :38-44
Objective To provide evidence for the necessity and safety of using favipiravir for the treatment of adult patients with non-severe forms of COVID-19 Subjects and methods Of the 168 study participants, 163 received at least one dose of the test drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c980f0628df5165008c255fb2a2334e8
https://doi.org/10.18565/epidem.2020.10.4.38-44
https://doi.org/10.18565/epidem.2020.10.4.38-44
Autor:
Marina G. Rusanova, Maria V. Otpushchennikova, Nataliya E. Kostina, Alexander A. Garbuzov, Antonina A. Ploskireva, Tatiana A. Ruzhentsova, Viсtoria S. Lesina, Moscow Jsc 'R-Pharm', Dmitriy A. Bistritskiy, Тatyana N. Markova, Viсtoria A. Razzhivina, Emilia N. Krasavina, Llc 'Mc Eco-safety', Alina S. Agaf'ina, Dzhavanshir M. Mustafaev, Tatyana N. Soluyanova, Rodion A. Oseshnyuk, Llc 'Neuroprofi', Yury F. Brook, Daria A. Khavkina, Olga V. Filon, Human Well-being Surveillance\\', Arkadiy V. Zintchenko, Oleg Yu. Bronov, Mikhail Yu. Samsonov, Konstantin A. Pokrovskiy, Tatiana N. Domostroeva, Adel Yu. Vafin, Sergey G. Shcherbak, Pavel V. Chukhlyaev, Elena P. Dmitrikova, Elena A. Kaplun, Evgeny I. Shults, Irina V. Shestakova, Diana V. Petina, Mariya V. Nikolskaya
Publikováno v:
Infectious diseases: News, Opinions, Training. 9:26-38
Material and methods An open-labeled, randomized, active-controlled multicenter trial of favipiravir in out- and hospitalized patients with mild to moderate COVID-19 was conducted Eligible patients were aged 18-60 years and had laboratory confirmed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c6a70b4eb8b78862c34d91995219d7
https://doi.org/10.33029/2305-3496-2020-9-4-26-38
https://doi.org/10.33029/2305-3496-2020-9-4-26-38